At EIRNABio, we develop cutting-edge platforms designed to unlock new insights into RNA translation and protein synthesis. Our proprietary platforms empower researchers in biotech and pharma to accelerate discovery, optimize drug development, and gain a deeper understanding of disease mechanisms.

Our Proprietary Platforms:

EIRNA BioConnect – A seamless Translatomics data integration and analysis hub, enabling researchers to extract meaningful insights from complex translatomic datasets.

cMAST (customized Multiplexed Assessment of Translation) – A high-throughput, customizable solution for investigating RNA translation with greater efficiency, speed, and cost-effectiveness than traditional methods.

sORF Explorer – A pioneering platform for identifying and characterizing previously overlooked small peptides, revealing novel therapeutic targets and biological functions.

Our platforms address critical challenges in translational research, offering scalable, customizable, and highly efficient solutions for identifying new drug targets, optimizing RNA-based therapeutics, and improving our understanding of gene regulation.

With deep scientific expertise and advanced methodologies, EIRNABio equips researchers with the tools needed to push the boundaries of discovery.

Contact us today to explore how our platform technologies can advance your research.